Cargando…

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

BACKGROUND: Data regarding the safety and effectiveness of aromatase inhibitors (AIs) as monotherapy or combined with gonadotropin-releasing hormone (GnRH) analogue in male breast cancer are scarce. METHODS: In this retrospective chart review, cases of male breast cancer patients treated with AIs wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zagouri, F, Sergentanis, T N, Koutoulidis, V, Sparber, C, Steger, G G, Dubsky, P, Zografos, G C, Psaltopoulou, T, Gnant, M, Dimopoulos, M-A, Bartsch, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681005/ https://www.ncbi.nlm.nih.gov/pubmed/23722469 http://dx.doi.org/10.1038/bjc.2013.255

Ejemplares similares

Early preclinical work with gonadotropin-releasing hormone analogues
por: Gordon, Keith
Publicado: (2023)

Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria
por: Brik, Tessa, et al.
Publicado: (2020)

Comparative efficacy of aromatase inhibitors and gonadotropin-releasing hormone analogue in increasing final height of idiopathic short stature boys: a network meta-analysis
por: Wang, Siqi, et al.
Publicado: (2023)

Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor?Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
por: Suh, Koung Jin, et al.
Publicado: (2017)

Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis
por: Di Lauro, Luigi, et al.
Publicado: (2015)

A Case of Cyclic Vomiting Syndrome Responding to Gonadotropin-Releasing Hormone Analogue
por: Shin, Young Kook, et al.
Publicado: (2010)

Anaphylactic reaction to gonadotropin‐releasing hormone analogues: a pediatric case report
por: Ricci, Franco, et al.
Publicado: (2018)

Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma
por: Zagouri, Flora, et al.
Publicado: (2007)

The Anticancer Activity Compared Between Triptorelin and a New Gonadotropin Releasing Hormone Analogue
por: Saleh-Abady, Mohammad Mirzaei, et al.
Publicado: (2009)

Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism
por: Tng, Eng-Loon, et al.
Publicado: (2020)

Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance
por: Huang-Doran, Isabel, et al.
Publicado: (2021)

Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine
por: Saleh, Farrah L., et al.
Publicado: (2023)

Incidence of Idiopathic Intracranial Hypertension in Individuals With Gonadotropin-Releasing Hormone Analogue Treatment for Gender Dysphoria in Sweden
por: Karamanis, Georgios, et al.
Publicado: (2023)

Effects of Gonadotropin-Releasing Hormone (GnRH) and Its Analogues on the Physiological Behaviors and Hormone Content of Tetrahymena pyriformis
por: Lajkó, Eszter, et al.
Publicado: (2019)

Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
por: Shi, Yuzhen, et al.
Publicado: (2022)

Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents
por: Nos, Andrea L., et al.
Publicado: (2022)

Body image and depression in girls with idiopathic precocious puberty treated with gonadotropin-releasing hormone analogue
por: Choi, Min-Seon, et al.
Publicado: (2016)

Gonadotropin-Releasing Hormone Analogue Treatment in Females with Moderately Early Puberty: No Effect on Final Height
por: Savaş-Erdeve, Şenay, et al.
Publicado: (2016)

Hormone-induced sperm-release in the critically endangered Booroolong frog (Litoria booroolongensis): effects of gonadotropin-releasing hormone and human chorionic gonadotropin
por: Silla, Aimee J, et al.
Publicado: (2019)

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
por: Pfeiler, G, et al.
Publicado: (2013)

Final height outcome of boys with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogue
por: Ma, Hua-mei, et al.
Publicado: (2013)

Effect of gonadotropin-releasing hormone analogue on final adult height among Jordanian children with precocious puberty
por: Swaiss, Hala H., et al.
Publicado: (2017)

Development of the gonadotropin‐releasing hormone system
por: Duittoz, Anne H., et al.
Publicado: (2022)

Gonadotropin-releasing Hormone Agonist Plus Aromatase Inhibitor in the Treatment of Uterine Leiomyoma in Near Menopause Patient: A Case Series Study
por: Moradan, Sanam
Publicado: (2018)

A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer
por: Zhang, Zhibo, et al.
Publicado: (2019)

Maternal aromatase inhibition via letrozole altered RFamide-related peptide-3 and gonadotropin-releasing hormone expression in pubertal female rats
por: Shaaban, Zahra, et al.
Publicado: (2022)

Health-related Quality of Life in Vacuum-Assisted Breast Biopsy: short-term effects, long-term effects and predictors
por: Domeyer, Philip J, et al.
Publicado: (2010)

Kisspeptin regulates gonadotropin-releasing hormone secretion in gonadotropin-releasing hormone/enhanced green fluorescent protein transgenic rats
por: Xue, Haogang, et al.
Publicado: (2013)

An evaluation of gonadotropin-releasing hormone analogue administered to gilts and sows on subsequent reproductive performance and piglet birth weight
por: Vangroenweghe, Frédéric, et al.
Publicado: (2016)

Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review
por: Andrikopoulou, Angeliki, et al.
Publicado: (2021)

Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia
por: Chen, Junyu, et al.
Publicado: (2022)

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy
por: Keane, Fergus, et al.
Publicado: (2016)

Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment
por: Taktaz, T., et al.
Publicado: (2015)

Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011)

Epigenetic Control of Gonadotropin Releasing Hormone Neurons
por: Kurian, Joseph R., et al.
Publicado: (2013)

Mathematical modeling of gonadotropin-releasing hormone signaling
por: Pratap, Amitesh, et al.
Publicado: (2017)

Gonadotropin-releasing hormone: incredible 50 years
por: Paulson, Richard J., et al.
Publicado: (2023)

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells
por: Luo, Xiaoping, et al.
Publicado: (2003)

Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses
por: Georgakopoulou, Rebecca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q8hruc2n9bqrrm8uvuc7307vp0